Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:14 AM
Ignite Modification Date:
2025-12-25 @ 4:14 AM
NCT ID:
NCT00733720
Eligibility Criteria:
Inclusion Criteria:
* Provide written informed consent
* Be male/female between the ages of 18-55
* Be in good physical and mental health as determined by interview and physical exam
* Have a body mass index between 18 and 30, inclusive
* Have no oral cavity pathology that would interfere with sublingual absorption of buprenorphine/naloxone or placebo
* Have negative qualitative urine toxicology screen for opioids, cocaine, benzodiazepines, and barbiturates prior to administration of the first dose of naltrexone
* Be able to comply with protocol requirements
* If female, have a negative pregnancy test and agree to use an acceptable method of birth control from date of consent and until two weeks after the last administration of study drug or placebo
Exclusion Criteria:
* please contact site for more information
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
55 Years
Study:
NCT00733720
Study Brief:
Protocol Section:
NCT00733720